Ascendis Pharma Ownership | Who Owns Ascendis Pharma?


OverviewForecastRevenueFinancialsChartTranscripts

Ascendis Pharma Ownership Summary


Ascendis Pharma is owned by 111.65% institutional investors, 0.78% insiders. Ra capital management is the largest institutional shareholder, holding 17.63% of ASND shares. MFS Mid Cap Growth Equity is the top mutual fund, with 2.21% of its assets in Ascendis Pharma shares.

ASND Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockAscendis Pharma111.65%0.78%-12.43%
SectorHealthcare Stocks 57.39%9.93%32.68%
IndustryBiotech Stocks 68.48%9.65%21.87%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Ra capital management10.11M17.63%$1.39B
Westfield capital management co lp5.53M9.64%$761.07M
Avoro capital advisors5.10M8.90%$702.54M
Fmr4.73M8.25%$650.99M
Artisan partners limited partnership4.45M7.76%$612.69M
Janus henderson group4.38M7.64%$602.91M
Capital investors2.86M4.99%$394.18M
T. rowe price investment management2.73M4.75%$375.23M
Price t rowe associates inc /md/2.28M3.98%$314.33M
Massachusetts financial services co /ma/1.87M3.26%$257.11M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Q global advisors219.46K25.98%$32.77M
Ra capital management10.11M18.53%$1.39B
Saturn v capital management198.98K10.73%$27.39M
Avoro capital advisors5.10M9.94%$702.54M
Resolute capital asset partners114.50K8.48%$15.76M
Vestal point capital, lp520.00K4.24%$71.59M
Evolutionary tree capital management30.11K4.22%$4.15M
Ghost tree capital86.72K3.70%$11.83M
Dafna capital management103.36K3.62%$14.23M
Westfield capital management co lp5.53M3.31%$761.07M

Top Buyers

HolderShares% AssetsChange
T. rowe price investment management2.73M0.23%960.50K
Capital investors2.86M0.07%753.86K
Ra capital management10.11M18.53%402.32K
Westfield capital management co lp5.53M3.31%394.47K
Vestal point capital, lp520.00K4.24%270.00K

Top Sellers

HolderShares% AssetsChange
Sofinnova investments---734.28K
Paradigm biocapital advisors lp---664.31K
Spyglass capital management---652.84K
Wellington management group llp704.17K0.02%-557.30K
Timessquare capital management---500.92K

New Positions

HolderShares% AssetsChangeValue
Soleus capital management144.00K1.25%144.00K$19.82M
Artal group101.10K0.35%101.10K$13.79M
Capital sarl23.81K0.08%23.81K$3.28M
Capital ltd /ca/19.15K0.11%19.15K$2.64M
Proficio capital partners12.53K0.00%12.53K$12.53K

Sold Out

HolderChange
Thurston, springer, miller, herd & titak-14.00
Hoey investments-24.00
Bogart wealth-34.00
Private trust co na-39.00
Entrypoint capital-193.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 2024221-5.96%64,027,7601.63%1110.93%1230.82%64-7.25%
Sep 30, 20242339.39%62,931,0943.91%1090.97%12110.00%68-
Jun 30, 20242134.93%60,561,767-0.18%1060.94%109-1.80%6836.00%
Mar 31, 20242031.50%60,669,5840.76%1060.94%11111.00%50-23.08%
Dec 31, 202320016.28%60,209,519-0.07%1060.93%10038.89%65-1.52%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
MFS Mid Cap Growth Equity1.32M2.21%12.79K
MFS Mid Cap Growth A1.30M2.18%-8.46K
Capital Group Growth Fnd of Amer Comp1.06M1.78%-
American Funds Growth Fund of Amer A1.06M1.78%-
T. Rowe Price US Mid-Cap Growth Equity1.02M1.71%286.30K
T. Rowe Price Mid-Cap Growth1.02M1.70%-
Janus Inst Mid Cap Growth CF976.88K1.63%-
Janus Henderson Enterprise D976.88K1.63%-
Artisan U.S. Mid-Cap Growth968.77K1.62%-63.55K
Artisan Mid Cap Investor968.77K1.62%-63.55K

ASND Ownership FAQ


Who Owns Ascendis Pharma?

Ascendis Pharma shareholders are primarily institutional investors at 111.65%, followed by 0.78% insiders and -12.43% retail investors. The average institutional ownership in Ascendis Pharma's industry, Biotech Stocks , is 68.48%, which Ascendis Pharma exceeds.

Who owns the most shares of Ascendis Pharma?

Ascendis Pharma’s largest shareholders are Ra capital management (10.11M shares, 17.63%), Westfield capital management co lp (5.53M shares, 9.64%), and Avoro capital advisors (5.1M shares, 8.90%). Together, they hold 36.17% of Ascendis Pharma’s total shares outstanding.

Does Blackrock own Ascendis Pharma?

BlackRock is not among the top 10 institutional shareholders of Ascendis Pharma.

Who is Ascendis Pharma’s biggest shareholder by percentage of total assets invested?

Q global advisors is Ascendis Pharma’s biggest shareholder by percentage of total assets invested, with 25.98% of its assets in 219.46K Ascendis Pharma shares, valued at 32.77M$.

Who is the top mutual fund holder of Ascendis Pharma shares?

MFS Mid Cap Growth Equity is the top mutual fund holder of Ascendis Pharma shares, with 2.21% of its total shares outstanding invested in 1.32M Ascendis Pharma shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools